Drive-Through Model for Anticoagulation Clinics During the COVID-19 Pandemic

The coronavirus disease of 2019 (COVID-19) has posed a major challenge for providers and patients. A large number of patients with atrial fibrillation, venous thromboembolism, or valvular heart disease are chronically anticoagulated with vitamin K antagonists and rely on frequent follow ups at antic...

Descripción completa

Detalles Bibliográficos
Autores principales: Rezaei Bookani, Kaveh, Minga, Iva, Chander, Manisha, Hankewych, Ksenia, Plassmeier, Matthew, Tafur, Alfonso
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
COVID-19 Consensus: Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7444151/
https://www.ncbi.nlm.nih.gov/pubmed/32822220
http://dx.doi.org/10.1177/1076029620947476

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7444151/
https://www.ncbi.nlm.nih.gov/pubmed/32822220
http://dx.doi.org/10.1177/1076029620947476

Ejemplares similares